Send us a text

Launching a successful drug takes more than just a brilliant idea - it takes a village of experts. 

In this episode, Peter Shadday, Chief Commercial Officer US and Global Head of Marketing Specialties at Zambon shares his insights on the commercialization of rare disease pharmaceutical products in the startup space. Peter knows firsthand the importance of patient support and health economics to develop a successful market access strategy. He also sheds light on the challenges in the rare disease field, from navigating the complexities of clinical trials to overcoming regulatory hurdles.

Tune in to this episode to learn from Peter's experiences and gain valuable insights on drug commercialization in rare diseases. 

See More ChalkTalkJim Episodes

Send us a text

Curing cancer is an iceberg more enormous than anyone could ever imagine.

In this episode, Pamela Bush, Chief Business Officer at Predictive Oncology, talks about her work connecting science and business to advance the discovery and development of drugs against cancer with the help of predictive AI and ML technology and the most extensive library of tumor samples.

Tune in to learn more about how Predictive Oncology impacts drug development!

See More ChalkTalkJim Episodes

Send us a text

The long-term care sector is an essential part of the health industry but has struggled for a while.

In this episode, Samantha Rapuk, Executive Director of Lutheran SeniorLife, talks about long-term care, breaking down the different care-continuum services, and the hardships she’s witnessed within non-profit institutions in the space. She reinforces the importance of caring for the sick, the elderly, and their families and speaks about how at Lutheran SeniorLife, every single worker keeps their residents at the center of what they do.

Tune in to learn more about the importance of funding long-term care and its impact!

See More ChalkTalkJim Episodes